Mes-Masson AM - Search Results

1

Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.

Ouellet V, Guyot MC, Le Page C, Filali-Mouhim A, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM. Ouellet V, et al. Int J Cancer. 2006 Aug 1;119(3):599-607. doi: 10.1002/ijc.21902. Int J Cancer. 2006. PMID: 16572426

2

Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.

Lounis H, Provencher D, Godbout C, Fink D, Milot MJ, Mes-Masson AM. Lounis H, et al. Exp Cell Res. 1994 Dec;215(2):303-9. doi: 10.1006/excr.1994.1346. Exp Cell Res. 1994. PMID: 7526992

3

Absence of human papillomavirus sequences in ovarian pathologies.

Trottier AM, Provencher D, Mes-Masson AM, Vauclair R, Coutlée F. Trottier AM, et al. J Clin Microbiol. 1995 Apr;33(4):1011-3. doi: 10.1128/jcm.33.4.1011-1013.1995. J Clin Microbiol. 1995. PMID: 7790425 Free PMC article.

4

Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.

Gu K, Mes-Masson AM, Gauthier J, Saad F. Gu K, et al. Cancer Lett. 1996 Feb 6;99(2):185-9. doi: 10.1016/0304-3835(95)04061-7. Cancer Lett. 1996. PMID: 8616823

5

Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer.

Provencher DM, Lounis H, Fink D, Drouin P, Mes-Masson AM. Provencher DM, et al. Tumour Biol. 1997;18(3):167-74. doi: 10.1159/000218027. Tumour Biol. 1997. PMID: 9143413

6

Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study.

Godard B, Foulkes WD, Provencher D, Brunet JS, Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P. Godard B, et al. Am J Obstet Gynecol. 1998 Aug;179(2):403-10. doi: 10.1016/s0002-9378(98)70372-2. Am J Obstet Gynecol. 1998. PMID: 9731846

7

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA. Tonin PN, et al. Am J Hum Genet. 1998 Nov;63(5):1341-51. doi: 10.1086/302099. Am J Hum Genet. 1998. PMID: 9792861 Free PMC article.

8

Mapping of chromosome 3p deletions in human epithelial ovarian tumors.

Lounis H, Mes-Masson AM, Dion F, Bradley WE, Seymour RJ, Provencher D, Tonin PN. Lounis H, et al. Oncogene. 1998 Nov 5;17(18):2359-65. doi: 10.1038/sj.onc.1202152. Oncogene. 1998. PMID: 9811467

9

Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites.

Manning AP, Mes-Masson AM, Seymour RJ, Tetrault M, Provencher DM, Tonin PN. Manning AP, et al. Mol Carcinog. 1999 Mar;24(3):218-25. doi: 10.1002/(sici)1098-2744(199903)24:3<218::aid-mc8>3.0.co;2-a. Mol Carcinog. 1999. PMID: 10204806

10

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history.

Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D. Tonin PN, et al. Clin Genet. 1999 May;55(5):318-24. doi: 10.1034/j.1399-0004.1999.550504.x. Clin Genet. 1999. PMID: 10422801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters